Date published: 2025-10-30

00800 4573 8000

SCBT Portrait Logo
Seach Input

UBE2U Ativadores

UBE2U,or "Ubiquitin-Conjugating Enzyme E2 U," is a protein that in humans is encoded by the UBE2U gene. This enzyme is a member of the ubiquitin-conjugating (E2) enzyme family, playing a crucial role in the ubiquitination pathway, a fundamental process for protein degradation and regulation within the cell.Ubiquitination is a process where ubiquitin, a small regulatory protein, is attached to substrates, typically signaling them for degradation via the proteasome or altering their cellular location, activity, or interactions. UBE2U functions as an E2 enzyme, which is responsible for the transfer of ubiquitin from the E1 activating enzyme to specific substrates, often with the assistance of an E3 ubiquitin ligase.The specific substrates and biological functions of UBE2U are still under research, but given the general importance of ubiquitination in cellular regulation, it is likely involved in multiple critical cellular processes. This can include cell cycle regulation, DNA repair, and response to stress or external stimuli.

UBE2U's role in ubiquitination suggests its involvement in various disease pathways, particularly those where protein degradation and regulation are disrupted, such as in cancer, neurodegenerative disorders, and inflammatory conditions. Abnormalities in ubiquitination processes are linked to the pathogenesis of these diseases, highlighting the significance of enzymes like UBE2U in maintaining cellular homeostasis.In summary, UBE2U is an important component of the ubiquitination pathway, with roles in various cellular processes and disease mechanisms. As such, it remains a subject of active research in the field of molecular biology and biochemistry.

VEJA TAMBÉM

Nome do ProdutoCAS #Numero de CatalogoQuantidadePrecoUso e aplicacaoNOTAS

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

O MG132, um inibidor do proteassoma, pode afetar as vias da ubiquitina-proteassoma, influenciando potencialmente a função do UBE2U.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Outro inibidor do proteassoma, o bortezomib, pode influenciar indiretamente o UBE2U ao afetar as vias de degradação das proteínas.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

A Lactacistina, um inibidor específico do proteassoma, pode modular os processos de ubiquitinação, afectando potencialmente o UBE2U.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

O PYR-41, um inibidor da enzima activadora da ubiquitina E1, pode afetar indiretamente a atividade do UBE2U na via da ubiquitinação.

DBeQ

177355-84-9sc-499943
10 mg
$330.00
1
(0)

Inibe a USP14, uma enzima deubiquitinadora, influenciando potencialmente as vias de ubiquitinação que envolvem o UBE2U.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modula as vias de degradação das proteínas, podendo ter efeitos indirectos na atividade do UBE2U.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$49.00
$367.00
$2030.00
18
(1)

Um fármaco imunomodulador, pode influenciar a homeostase proteica e potencialmente a função do UBE2U.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$98.00
$140.00
$306.00
$459.00
$1224.00
$1958.00
1
(1)

Semelhante à talidomida, afecta as vias de degradação das proteínas, podendo afetar o UBE2U.